Researchers at the University of California, Riverside have developed a cheap, simple test that identifies counterfeit and ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

After decades of slow progress in understanding and developing effective treatments for Alzheimer’s disease, scientists are ...

HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, ...

Scientists engineered the first fully synthetic brain tissue model. It’s fully functional brain tissue that they can use to test neurological drugs. They believe the discovery will lead them to better ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...